276 related articles for article (PubMed ID: 11069069)
21. Invariant chain as a vehicle to load antigenic peptides on human MHC class I for cytotoxic T-cell activation.
Wälchli S; Kumari S; Fallang LE; Sand KM; Yang W; Landsverk OJ; Bakke O; Olweus J; Gregers TF
Eur J Immunol; 2014 Mar; 44(3):774-84. PubMed ID: 24293164
[TBL] [Abstract][Full Text] [Related]
22. Invariant chain and DM edit self-peptide presentation by major histocompatibility complex (MHC) class II molecules.
Katz JF; Stebbins C; Appella E; Sant AJ
J Exp Med; 1996 Nov; 184(5):1747-53. PubMed ID: 8920863
[TBL] [Abstract][Full Text] [Related]
23. Invariant chains with the class II binding site replaced by a sequence from influenza virus matrix protein constrain low-affinity sequences to MHC II presentation.
Carstens C; Newman DK; Bohlen H; König A; Koch N
Int Immunol; 2000 Nov; 12(11):1561-8. PubMed ID: 11058576
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
[TBL] [Abstract][Full Text] [Related]
25. Nonobese diabetic mice display elevated levels of class II-associated invariant chain peptide associated with I-Ag7 on the cell surface.
Bhatnagar A; Milburn PJ; Lobigs M; Blanden RV; Gautam AM
J Immunol; 2001 Apr; 166(7):4490-7. PubMed ID: 11254705
[TBL] [Abstract][Full Text] [Related]
26. Rescue of cytotoxic function in the CD8alpha knockout mouse by removal of MHC class II.
Riddle DS; Miller PJ; Vincent BG; Kepler TB; Maile R; Frelinger JA; Collins EJ
Eur J Immunol; 2008 Jun; 38(6):1511-21. PubMed ID: 18465769
[TBL] [Abstract][Full Text] [Related]
27. An altered invariant chain protein with an antigenic peptide in place of CLIP forms SDS-stable complexes with class II alphabeta dimers and facilitates highly efficient peptide loading.
Barton GM; Rudensky AY
Int Immunol; 1998 Aug; 10(8):1159-65. PubMed ID: 9723702
[TBL] [Abstract][Full Text] [Related]
28. The CLIP-substituted invariant chain efficiently targets an antigenic peptide to HLA class II pathway in L cells.
Fujii S; Senju S; Chen YZ; Ando M; Matsushita S; Nishimura Y
Hum Immunol; 1998 Oct; 59(10):607-14. PubMed ID: 9757942
[TBL] [Abstract][Full Text] [Related]
29. CLIP-derived self peptides bound to MHC class II molecules of medullary thymic epithelial cells differ from those of cortical thymic epithelial cells in their diversity, length, and C-terminal processing.
Kasai M; Kropshofer H; Vogt AB; Kominami E; Mizuochi T
Eur J Immunol; 2000 Dec; 30(12):3542-51. PubMed ID: 11169395
[TBL] [Abstract][Full Text] [Related]
30. Concomitant Disruption of
Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
[TBL] [Abstract][Full Text] [Related]
31. Distinct peptide loading pathways for MHC class II molecules associated with alternative Ii chain isoforms.
Bikoff EK; Kenty G; Van Kaer L
J Immunol; 1998 Apr; 160(7):3101-10. PubMed ID: 9531264
[TBL] [Abstract][Full Text] [Related]
32. Tetraspan microdomains distinct from lipid rafts enrich select peptide-MHC class II complexes.
Kropshofer H; Spindeldreher S; Röhn TA; Platania N; Grygar C; Daniel N; Wölpl A; Langen H; Horejsi V; Vogt AB
Nat Immunol; 2002 Jan; 3(1):61-8. PubMed ID: 11743588
[TBL] [Abstract][Full Text] [Related]
33. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
34. Relaxed DM requirements during class II peptide loading and CD4+ T cell maturation in BALB/c mice.
Bikoff EK; Wutz G; Kenty GA; Koonce CH; Robertson EJ
J Immunol; 2001 Apr; 166(8):5087-98. PubMed ID: 11290790
[TBL] [Abstract][Full Text] [Related]
35. Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.
Ramachandra L; Kovats S; Eastman S; Rudensky AY
J Immunol; 1996 Mar; 156(6):2196 - 2204. PubMed ID: 8690909
[TBL] [Abstract][Full Text] [Related]
36. A critical, invariant chain-independent role for H2-M in antigen presentation.
Swier K; Brown DR; Bird JJ; Martin WD; Van Kaer L; Reiner SL
J Immunol; 1998 Jan; 160(2):540-4. PubMed ID: 9551884
[TBL] [Abstract][Full Text] [Related]
37. Highly restricted T cell repertoire shaped by a single major histocompatibility complex-peptide ligand in the presence of a single rearranged T cell receptor beta chain.
Fukui Y; Hashimoto O; Inayoshi A; Gyotoku T; Sano T; Koga T; Gushima T; Sasazuki T
J Exp Med; 1998 Sep; 188(5):897-907. PubMed ID: 9730891
[TBL] [Abstract][Full Text] [Related]
38. A study of complexes of class II invariant chain peptide: major histocompatibility complex class II molecules using a new complex-specific monoclonal antibody.
Eastman S; Deftos M; DeRoos PC; Hsu DH; Teyton L; Braunstein NS; Hackett CJ; Rudensky A
Eur J Immunol; 1996 Feb; 26(2):385-93. PubMed ID: 8617308
[TBL] [Abstract][Full Text] [Related]
39. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
40. What to do with HLA-DO/H-2O two decades later?
Welsh R; Song N; Sadegh-Nasseri S
Immunogenetics; 2019 Mar; 71(3):189-196. PubMed ID: 30683973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
